-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
25-Hydroxyvitamin D3, also known as calcidiol, is a form of vitamin D that is produced in the body when sunlight exposure causes the skin to produce vitamin D3.
It is also available as a dietary supplement, and is used to treat vitamin D deficiency and other conditions related to vitamin D insufficiency.
The synthetic routes of 25-hydroxyvitamin D3 are varied and can be divided into two main categories: chemical synthesis and biotechnological synthesis.
Chemical synthesis is the process of creating a compound using chemical reactions and reagents.
There are several chemical synthesis methods for producing 25-hydroxyvitamin D3, including the Friedel-Crafts route, the Wohl-Doebner point synthesis, and the Vogel-Hagen-Harrison (VHH) method.
The Friedel-Crafts route involves the reaction of boric acid with a halogenated derivative of 7-dehydrocholesterol, followed by reduction of the resulting intermediate with hydrogen in the presence of a transition metal catalyst.
This process produces a mixture of various vitamin D metabolites, including 25-hydroxyvitamin D3.
The Wohl-Doebner point synthesis involves the reaction of cholesterol with hydrogen peroxide in the presence of a Lewis acid catalyst, such as aluminum chloride or boron trifluoride.
The resulting intermediate is then reduced with hydrogen in the presence of a reducing agent, such as lithium aluminum hydride, to produce 25-hydroxyvitamin D3.
The VHH method involves the reaction of 7-dehydrocholesterol with a Grignard reagent, followed by hydrogenation to produce 25-hydroxyvitamin D3.
Biotechnological synthesis involves the use of living organisms, such as bacteria or yeast, to produce a desired compound.
One of the most commonly used biotechnological methods for producing 25-hydroxyvitamin D3 is through the use of yeast cells, which are engineered to express the enzyme 7-dehydrocholesterol reductase.
This enzyme is responsible for converting 7-dehydrocholesterol to vitamin D3, which is then converted to 25-hydroxyvitamin D3 through the action of other enzymes in the vitamin D biosynthesis pathway.
There are several advantages to using biotechnological synthesis methods for producing 25-hydroxyvitamin D3, including the fact that the process is more environmentally friendly than traditional chemical synthesis methods, as it does not involve the use of toxic reagents or solvents.
Additionally, biotechnological synthesis allows for the production of large quantities of 25-hydroxyvitamin D3 at a lower cost than traditional chemical synthesis methods.
It is also worth noting that, synthetic route of 25-hydroxyvitamin D3 can have a great impact on its purity and efficacy, different routes may produce different purity and efficacy of the final product, so it's important to select the appropriate route depending on the intended use.
In conclusion, 25-hydroxyvitamin D3 is an important nutrient that is used to treat vitamin D deficiency and other related conditions.
The synthetic routes of 25-hydroxyvitamin D3 can be divided into two main categories: chemical synthesis and biotechnological synthesis.
Both methods have advantages and disadvantages, and the choice of route depends on the intended use.